|
Gonzalez-Cao M, Puertolas T, Riveiro M, Munoz-Couselo E, Ortiz C, Paredes R, Podzamczer D, Manzano JL, Molto J, Revollo B, Carrera C, Mateu L, Fancelli S, Espinosa E, Clotet B, Martinez-Picado J, Cerezuela P, Soria A, Marquez I, Mandala M, Berrocal A; Spanish Melanoma Group (GEM). Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM). J Immunother Cancer. 2021 Mar;9(3):e001664. doi: 10.1136/jitc-2020-001664. Erratum In: J Immunother Cancer. 2022 Feb;10(2): PubMed PMID: 33782108; PubMed Central PMCID: PMC8009216.
AÑO: 2021; IF: 12.469
|
33782108
|
Lopez-Martin JA, Arance Fernandez A, Rios-Martin JJ, Hernandez-Losa J, Alos Hernandez L, Cerezuela Fuentes P, Ortiz Reina S, Ortega Izquierdo E, Marti RM, Soberino Garcia J, Ferrer Fabrega B, Rodriguez Peralto JL; ABSOLUT-BRAF Study Group. Frequency and Clinicopathological Profile Associated with Braf Mutations in Patients with Advanced Melanoma in Spain. Transl Oncol. 2020 Jun;13(6):100750. doi: 10.1016/j.tranon.2020.100750. Epub 2020 May 15. PubMed PMID: 32422543; PubMed Central PMCID: PMC7229288.
AÑO: 2020; IF: 4.243
|
|
Pinero-Madrona A, Gomez-Ruiz AJ, Ruiz-Merino G, Martinez-Barba E, Cerezuela-Fuentes P, Rodriguez-Lopez JN, Cabezas-Herrera J. Prognostic value of the Breslow:diameter ratio in cutaneous melanoma. J Am Acad Dermatol. 2019 Mar;80(3):806-808. doi: 10.1016/j.jaad.2018.09.034. Epub 2018 Oct 2. No abstract available. PubMed PMID: 30287323.
AÑO: 2019; IF: 8.277
|
|
Pinero-Madrona A, Ruiz-Merino G, Cerezuela Fuentes P, Martinez-Barba E, Rodriguez-Lopez JN, Cabezas-Herrera J. Mitotic rate as an important prognostic factor in cutaneous malignant melanoma. Clin Transl Oncol. 2019 Oct;21(10):1348-1356. doi: 10.1007/s12094-019-02064-4. Epub 2019 Feb 19. PubMed PMID: 30783917.
AÑO: 2019; IF: 2.737
|
|
Garcia de Guadiana-Romualdo L, Cerezuela-Fuentes P, Espanol-Morales I, Esteban-Torrella P, Jimenez-Santos E, Hernando-Holgado A, Albaladejo-Oton MD. Prognostic value of procalcitonin and lipopolysaccharide binding protein in cancer patients with chemotherapy-associated febrile neutropenia presenting to an emergency department. Biochem Med (Zagreb). 2019 Feb 15;29(1):010702. doi: 10.11613/BM.2019.010702. Epub 2018 Dec 15. PubMed PMID: 30591812; PubMed Central PMCID: PMC6294152.
AÑO: 2019; IF: 2.114
|